Product Description
Halkeran (Chlorambucil) is an alkylating agent used primarily in the treatment of certain cancers, including chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), and Hodgkin's lymphoma. Chlorambucil interferes with the DNA of cancer cells, inhibiting their ability to reproduce and proliferate. Chlorambucil is an alkylating agent that works by adding an alkyl group to the DNA molecule, which leads to the formation of DNA cross-links. This process prevents DNA from being able to replicate and causes cell death. By interfering with DNA replication and transcription, it inhibits the growth and division of cancer cells. Chlorambucil is considered a "mustard gas" derivative, a type of chemotherapy that acts at the cellular level.